Novo Sues Orbicular to Block Copies of Saxenda Weight-Loss Drug – Bloomberg Law

Novo Nordisk AS alleges that a generic version of Saxenda proposed by Orbicular Pharmaceutical Technologies Pvt. Ltd. infringes 18 patents for the …